Skip to main content
. 2017 May 5;9(21):18039–18045. doi: 10.1021/acsami.7b02867

Figure 2.

Figure 2

Transfer characteristics of the pristine devices with (a) 3MPA, (b) TBAI, and (c) MAI ligands. Transfer characteristics of the devices with (d) 3MPA, (e) TBAI, and (f) MAI ligands after BV treatment. Transfer characteristics in the linear and semilogarithmic scale are shown in black and red, respectively.